Navigation Links
Bend Research Presents Drug Delivery Advancements at Controlled Release Society Annual Meeting
Date:7/16/2013

Bend, Oregon (PRWEB) July 16, 2013

Bend Research Inc., a leading independent scientific development and manufacturing company, today announced a full schedule of events at the 40th Annual Meeting & Exposition of the Controlled Release Society (CRS), being held July 21–24 at the Hawaii Convention Center in Honolulu.

“We are looking forward to returning to the CRS meeting this year to share our recent advancements in drug delivery,” said David Lyon, Senior Vice President at Bend Research. “We also are eager to meet with clients and peers to discuss the latest developments in topics ranging from oral solubilization technology to multiparticulate oral drug delivery systems.”

David Lyon, Ph.D., will be moderating the scientific session titled, “Solubilization Technology – A Key Enabler for the Delivery of Poorly Soluble Drugs,” July 22 at 10:30 a.m.–12:00 p.m. HAST.

In addition, Brett Caldwell, Ph.D., will participate in the following presentations and talks during the CRS meeting:

  • Presentation during the soapbox session titled, “Enabling Pharmacokinetic Control of Solubilized Forms,” July 21 at 1:50–1:55 p.m. HAST.
  • Presentation of a poster (board 501, session 1) titled, “The Utility of Modified-Release, Osmotic Tablet Technology in the Early Stages of Pharmaceutical Development,” July 22 from 9:30-10:30 a.m. HAST.
  • Discussion in the roundtable session titled, “Multiparticulate Oral Drug Delivery Systems for Fixed Dose Combinations,” July 23 at 4:00–5:30 p.m. HAST. This will be an overview of the multiparticulate opportunities for fixed dose combinations and will include case studies to illustrate the challenges and best practices.

Attendees can visit Booth #303 to learn more about Bend Research and its services and technologies.

Contact: To schedule a meeting with Bend Research experts or for any other press inquiry, please contact Phoenix Barringer at phoenix.barringer(at)bendresearch(dot)com or 541-382-4100.

About Bend Research
For more than 35 years, Bend Research Inc. has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company’s ability to develop, advance, and commercialize pharmaceutical technologies, which grow from a solid base of scientific and engineering fundamental understanding.

Bend Research Inc. provides several capabilities, including formulation and dosage-form support, assists in process development and optimization, manufactures clinical trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization. The company is a leader in novel formulations, including spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies. With more than 285 employees, Bend Research Inc. is based in six state-of-the-art facilities in Bend, Oregon, USA.

Follow Bend Research on LinkedIn at http://www.linkedin.com/company/bend-research. For more information, visit http://www.bendresearch.com.

###

Read the full story at http://www.prweb.com/releases/2013/7/prweb10930841.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioInformatics LLC—New Report Finds High Degree of Satisfaction With Instrumentation Performance Among Researchers
2. Sarah Cannon Research Institute Implements Virtify CTRR
3. York Nanocentre researchers image individual atoms in a living catalytic reaction
4. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
5. Comprehensive Topical Reports by Transparency Market Research Now Available at MarketPublishers.com
6. Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
7. BioInformatics, LLC New Market Research Report – Life Science Instruments: Brand Performance
8. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
9. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
10. Allegheny General Hospital Neurosurgeon Receives NIH Grant for Brain Aneurysm Research
11. Elsevier Promotes Local Research Efforts in Pakistan Through "Quiz for Science"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... and WASHINGTON , March 28, ... provider, GENEWIZ, will launch single-cell sequencing during the American Association ... E. Washington Convention Center in Washington, D.C. ... to perform differential gene expression of thousands of cells ... Experts on-hand at AACR ...
(Date:3/28/2017)... March 28, 2017 Dr. Chris ... sciences corporation Anpac Bio-Medical Science Company , ... international record, processing and reporting over 40,000 cases ... Analysis" (CDA) liquid biopsy tests. ... Laureate Summit publications, Anpac Bio,s CDA medical devices ...
(Date:3/28/2017)... March 28, 2017 Focus ... unpredictable sector due to the scientifically intensive operations ... medical, agricultural, environmental, and industrial. In today,s pre-market research, ... Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: OVAS), ... Inc. (NASDAQ: OCUL ). Learn more ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Harvill as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished ... and operations. , Avomeen is a leader in a wide range of ...
Breaking Biology Technology:
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 ... Senate Judiciary Committee, Janice Kephart of Identity ... President Donald Trump,s "Executive Order: Protecting the ... (Jan. 27, 2017):  "As President Trump,s ,Travel ... Circuit has now essentially banned the travel ban, it ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
Breaking Biology News(10 mins):